Erratum: Author’s Affiliation Correction. Type Ⅱ human epidermal growth factor receptor heterogeneity is a poor prognosticator for type Ⅱ human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019;Aug 6;7 (15): 1964-1977)  

作　　者：Akio Kaito Takeshi Kuwata Masanori Tokunaga Kohei Shitara Reo Sato Tetsuo Akimoto Takahiro Kinoshita 

机构地区：[1]Gastric Surgery Division,National Cancer Center Hospital East,Kashiwa 277-8577,Japan [2]Department of Pathology and Clinical Laboratories,National Cancer Center Hospital East,Kashiwa 277-8577,Japan [3]Department of Gastrointestinal Oncology,National Cancer Center Hospital East,Kashiwa 277-8577,Japan [4]Course of Advanced Clinical Research of Cancer,Juntendo University Graduate School of Medicine,Tokyo 163-8001,Japan [5]Exploratory Oncology Research and Clinical Trial Center(EPOC),National Cancer Center Hospital East,Kashiwa 277-8577,Japan [6]Department of Radiation Oncology,National Cancer Center Hospital East,Kashiwa 277-8577,Japan

出　　处：《World Journal of Clinical Cases》2020年第21期5494-5495,共2页世界临床病例杂志

摘　　要：Correction to"Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer"World J Clin Cases 2019;7(15):1964-1977.In this article,one of the affiliation of the first author was lacked.Akio Kaito,the first author,belonged to Course of Advanced Clinical Research of Cancer,Juntendo University Graduate School of Medicine,Tokyo 163-8001,Japan.

关 键 词：CORRECTION 

分 类 号：R73[医药卫生—肿瘤]